Emily Charrier

1.7k total citations · 1 hit paper
29 papers, 1.4k citations indexed

About

Emily Charrier is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Emily Charrier has authored 29 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 8 papers in Hematology and 7 papers in Oncology. Recurrent topics in Emily Charrier's work include Immune Cell Function and Interaction (18 papers), Immunotherapy and Immune Responses (8 papers) and T-cell and B-cell Immunology (7 papers). Emily Charrier is often cited by papers focused on Immune Cell Function and Interaction (18 papers), Immunotherapy and Immune Responses (8 papers) and T-cell and B-cell Immunology (7 papers). Emily Charrier collaborates with scholars based in France, Canada and Switzerland. Emily Charrier's co-authors include Thierry Walzer, Sébastien Viel, Jacques Bienvenu, Jacqueline Marvel, Antoine Marçais, Thomas Henry, Uzma Hasan, Laurent Buffat, Emilie Debien and Simon de Bernard and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Emily Charrier

28 papers receiving 1.3k citations

Hit Papers

TGF-β inhibits the activation and functions of NK cells b... 2016 2026 2019 2022 2016 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
    2016 493 citations Sébastien Viel, Antoine Marçais et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily Charrier France 13 1.1k 319 208 198 162 29 1.4k
William van der Touw United States 12 985 0.9× 230 0.7× 243 1.2× 104 0.5× 103 0.6× 25 1.3k
Colleen M. Lau United States 22 1.5k 1.4× 271 0.8× 381 1.8× 211 1.1× 228 1.4× 37 1.9k
Achilleas Floudas Ireland 19 679 0.6× 227 0.7× 244 1.2× 139 0.7× 72 0.4× 32 1.3k
Cherry Kingsley United Kingdom 13 1.8k 1.7× 196 0.6× 168 0.8× 298 1.5× 194 1.2× 15 2.2k
Genny Del Zotto Italy 17 1.4k 1.3× 658 2.1× 347 1.7× 78 0.4× 171 1.1× 39 1.8k
Anatolij Horuzsko United States 19 1.4k 1.3× 149 0.5× 176 0.8× 119 0.6× 60 0.4× 39 1.7k
Katia Mayol France 9 1.0k 0.9× 152 0.5× 213 1.0× 188 0.9× 70 0.4× 10 1.2k
Rachel Golub France 24 1.3k 1.2× 139 0.4× 373 1.8× 477 2.4× 209 1.3× 52 1.7k
Debbie L. Hardie United Kingdom 18 603 0.6× 232 0.7× 320 1.5× 99 0.5× 135 0.8× 34 1.2k
William D. Hastings United States 10 1.7k 1.6× 493 1.5× 376 1.8× 81 0.4× 86 0.5× 13 2.0k

Countries citing papers authored by Emily Charrier

Since Specialization
Citations

This map shows the geographic impact of Emily Charrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Charrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Charrier more than expected).

Fields of papers citing papers by Emily Charrier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Charrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Charrier. The network helps show where Emily Charrier may publish in the future.

Co-authorship network of co-authors of Emily Charrier

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Charrier. A scholar is included among the top collaborators of Emily Charrier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Charrier. Emily Charrier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fernández, Eugenio, Denis Migliorini, Emily Charrier, et al.. (2024). A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors. Cancer Research Communications. 4(8). 2089–2100.
2.
Charrier, Emily, Olivier Rohr, Aurélien Lathuilière, et al.. (2023). Engineering a versatile and retrievable cell macroencapsulation device for the delivery of therapeutic proteins. iScience. 26(8). 107372–107372. 2 indexed citations
3.
Lathuilière, Aurélien, Emily Charrier, Olivier Rohr, et al.. (2022). Immortalized human myoblast cell lines for the delivery of therapeutic proteins using encapsulated cell technology. Molecular Therapy — Methods & Clinical Development. 26. 441–458. 8 indexed citations
4.
Charrier, Emily, et al.. (2021). A Functional GM-CSF Receptor on Dendritic Cells Is Required for Efficient Protective Anti-Tumor Immunity. SHILAP Revista de lepidopterología. 1(3). 240–252. 1 indexed citations
5.
6.
Besson, Laurie, Benoîte Méry, Magali Morelle, et al.. (2021). Cutting Edge: mTORC1 Inhibition in Metastatic Breast Cancer Patients Negatively Affects Peripheral NK Cell Maturation and Number. The Journal of Immunology. 206(10). 2265–2270. 9 indexed citations
7.
Charrier, Emily, et al.. (2021). A Quantitative ELISA Protocol for Detection of Specific Human IgG against the SARS-CoV-2 Spike Protein. Vaccines. 9(7). 770–770. 11 indexed citations
8.
Fauteux‐Daniel, Sébastien, Sébastien Viel, Laurie Besson, et al.. (2018). Deletion of Inflammasome Components Is Not Sufficient To Prevent Fatal Inflammation in Models of Familial Hemophagocytic Lymphohistiocytosis. The Journal of Immunology. 200(11). 3769–3776. 5 indexed citations
9.
Besson, Laurie, Emily Charrier, Lionel Karlin, et al.. (2018). One-Year Follow-Up of Natural Killer Cell Activity in Multiple Myeloma Patients Treated With Adjuvant Lenalidomide Therapy. Frontiers in Immunology. 9. 704–704. 13 indexed citations
10.
Walzer, Thierry, et al.. (2017). Late‐onset hemophagocytic lymphohistiocytosis with neurological presentation. Clinical Case Reports. 5(11). 1743–1749. 1 indexed citations
11.
Viel, Sébastien, Laurie Besson, Emily Charrier, et al.. (2016). Alteration of Natural Killer cell phenotype and function in obese individuals. Clinical Immunology. 177. 12–17. 90 indexed citations
12.
Zannetti, Claudia, Guillaume Roblot, Emily Charrier, et al.. (2016). Characterization of the Inflammasome in Human Kupffer Cells in Response to Synthetic Agonists and Pathogens. The Journal of Immunology. 197(1). 356–367. 56 indexed citations
13.
Daussy, Cécile, Fabrice Faure, Katia Mayol, et al.. (2014). T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow. The Journal of Experimental Medicine. 211(3). 563–577. 439 indexed citations
14.
15.
Viel, Sébastien, Emily Charrier, Antoine Marçais, et al.. (2013). Monitoring NK cell activity in patients with hematological malignancies. OncoImmunology. 2(9). e26011–e26011. 36 indexed citations
16.
Soudeyns, Hugo, Emily Charrier, Paulo Cordeiro, et al.. (2012). Reconstitution of protective immune responses against CMV and VZV does not require disease development in paediatric recipients of umbilical cord blood transplantation. (126.4). The Journal of Immunology. 188(1_Supplement). 126.4–126.4. 1 indexed citations
17.
Charrier, Emily, et al.. (2012). Reconstitution of maturating and regulatory lymphocyte subsets after cord blood and BMT in children. Bone Marrow Transplantation. 48(3). 376–382. 34 indexed citations
18.
Herblot, Sabine, et al.. (2012). Defects in CD54 and CD86 Up-regulation by Plasmacytoid Dendritic Cells During Pregnancy. Immunological Investigations. 41(5). 497–506. 14 indexed citations
19.
Michaud, Annie, Rkia Dardari, Emily Charrier, et al.. (2010). IL-7 Enhances Survival of Human CD56bright NK Cells. Journal of Immunotherapy. 33(4). 382–390. 47 indexed citations
20.
Charrier, Emily, Rkia Dardari, Annie Michaud, Paulo Cordeiro, & Michel Duval. (2007). Immunologie néonatale et greffe de sang de cordon. médecine/sciences. 23(11). 975–979. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William van der Touw Breakdown of academic impact, for papers by Colleen M. Lau Breakdown of academic impact, for papers by Achilleas Floudas Breakdown of academic impact, for papers by Cherry Kingsley Breakdown of academic impact, for papers by Genny Del Zotto Breakdown of academic impact, for papers by Anatolij Horuzsko Breakdown of academic impact, for papers by Katia Mayol Breakdown of academic impact, for papers by Rachel Golub Breakdown of academic impact, for papers by Debbie L. Hardie Breakdown of academic impact, for papers by William D. Hastings
Rankless by CCL
2026